Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY10 | O00398 | 9/20 | 0.69 |
| ▸ | GPR34 | Q9UPC5 | 3/20 | 0.69 |
| ▸ | DGKA | P23743 | 1/20 | 0.56 |
| ▸ | FABP3 | P05413 | 1/20 | 0.52 |
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14326981 | 1.00 | P2RY10 (0.69) | P2RY10GPR34DGKAFABP3HTR2C | |
| SCHEMBL21581255 | 1.00 | P2RY10 (0.69) | P2RY10GPR34DGKAFABP3HTR2C | |
| SCHEMBL10823812 | 0.93 | DGKA (0.62) | P2RY10GPR34DGKAFABP3 | |
| SCHEMBL14240582 | 0.92 | P2RY10 (0.72) | P2RY10GPR34 | |
| SCHEMBL12629387 | 0.90 | P2RY10 (0.69) | P2RY10GPR34DGKAFABP3 | |
| SCHEMBL26062154 | 0.88 | P2RY10 (0.68) | P2RY10GPR34DGKAFABP3 | |
| SCHEMBL4803506 | 0.88 | ALDH1A1 (0.69) | P2RY10GPR34 | |
| SCHEMBL26061672 | 0.85 | P2RY10 (0.64) | P2RY10GPR34DGKA | |
| SCHEMBL14758262 | 0.84 | FABP3 (0.70) | P2RY10GPR34DGKAFABP3 | |
| SCHEMBL25665820 | 0.84 | FABP3 (0.70) | P2RY10GPR34DGKAFABP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220160632-A1 | PEGYLATED LIPOSOMES AND METHODS OF USE | ACCESS TO ADVANCED HEALTH INSTITUTE | 2022-05-26 | — | — | US | disclosed |
| US-20210113641-A1 | EXTRACTION OF PLANT SOURCE \"MEDICINAL SOUP\" AND MANUAL PREPARATION OF \"HERBAL MEDICINE\" AND RELATED PRODUCTS | BEIJING BAISHIHEKANG PHARMACEUTICAL TECHNOLOGY (BSJPHARMA) CO., LTD (CN) | 2021-04-22 | — | — | US | disclosed |
| US-20210108198-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT AND RELATED PRODUCTS THEREOF | BEIJING BAISHIHEKANG PHARMACEUTICAL TECHNOLOGY (BSJPHARMA) CO., LTD (CN) | 2021-04-15 | — | — | US | disclosed |
| US-20210100905-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT, AND RELATED PRODUCTS | BEIJING BAISHIHEKANG PHARMACEUTICAL TECHNOLOGY (BSJPHARMA) CO., LTD (CN) | 2021-04-08 | — | — | US | disclosed |
| US-20200138715-A1 | Pegylated Liposomes and Methods of Use | INFECTIOUS DISEASE RESEARCH INSTITUTE (US) | 2020-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210100905-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT, AND RELATED PRODUCTS | TRDMT1, SNRPE, HNRNPAB | P2RY10 4678/4885GPR34 3962/4885DGKA 2348/4885 |
| US-20220160632-A1 | PEGYLATED LIPOSOMES AND METHODS OF USE | LIPA, SGMS1, SGMS2 | P2RY10 4695/4885GPR34 3982/4885DGKA 141/4885 |
| US-20200138715-A1 | Pegylated Liposomes and Methods of Use | LIPA, SGMS1, SGMS2 | P2RY10 4695/4885GPR34 3982/4885DGKA 141/4885 |
| US-20210113641-A1 | EXTRACTION OF PLANT SOURCE \"MEDICINAL SOUP\" AND MANUAL PREPARATION OF \"HERBAL MEDICINE\" AND RELATED PRODUCTS | CHMP4B, EXOSC5, FIP1L1 | P2RY10 3400/4885GPR34 3612/4885DGKA 2017/4885 |
| US-20210108198-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT AND RELATED PRODUCTS THEREOF | TRDMT1, HNRNPAB, HNRNPA1 | P2RY10 4517/4885GPR34 3580/4885DGKA 2734/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.